EFFICACY AND SAFETY OF ENDOSURGICAL BIOPSY IN CHILDREN WITH CHRONIC LIVER DISEASE


Cite item

Full Text

Abstract

Background. A variety of pathomorphological manifestations of chronic liver diseases (CLD) in children necessitates a sufficient size for a reliable morphological assessment of the size of the hepatobioptate. Marked fibrotic changes in liver tissue and the presence of a high incidence of hemostatic disorders increase the risk of complications during a biopsy. In view of this, the liver biopsy method should be selected in accordance with the amount of biopsy material necessary for an accurate verification of the diagnosis, being the most effective and at the same time the safest with respect to the risks of complications both during the biopsy and in the postoperative period. Materials and methods. The one-center bi-directional (retro- and prospective) study included 175 patients with CLD: 75 children who made up the main group had a liver biopsy by edge resection, and 100 patients with CLD included in the comparison group had previously undergone a biopsy. A comparative analysis of the duration of the biopsy, the presence and nature of the complications, the number of portal tracts contained in the obtained samples, the number of fragmented and uninformative biopsy samples during the behavior of the puncture biopsy and marginal resection of the liver tissue under laparoscopic control was performed. Results. Hepatobioptate marginal resection took an average time of 21.7 minutes. No complications were noted. A puncture biopsy took an average of 19.4 minutes. In four cases, the development of complications was noted (two cases being the bleeding from the puncture site, one case being a violation of the integrity of the gallbladder wall with the development of local biliary peritonitis, the development of pneumothorax due to lung damage). According to the Mann - Whitney criterion, statistically significant differences in the number of portal tracts in the main and comparison groups were revealed (p=0.000). The number of portal tracts during the regional resection of the hepatobioptate averaged 93, while those happened during the puncture averaged 5. The information content of the biopsy samples in the main group was 100%. Fragmentation of biopsy material was not noted. In the comparison group, the informative value of biopsy samples was 86%, 20% of biopsy samples were fragmented.

Full Text

Restricted Access

About the authors

Polina V. Khrolenko

National Medical Research Center of Children’s Health

Email: polinakhrolenko@gmail.com

Sergei P. Yatsyk

National Medical Research Center of Children’s Health

Elena Yu. D'yakonova

National Medical Research Center of Children’s Health

Andrei N. Surkov

National Medical Research Center of Children’s Health

Elena L. Tumanova

Pirogov Russian National Research Medical University

Aleksei A. Gusev

National Medical Research Center of Children’s Health

Kirill A. Kulikov

National Medical Research Center of Children’s Health

References

  1. Colloredo G, Guido M, Sonzogni A, Leanardo G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder disease. J Hepatol 2003; 39 (2): 239-44. doi: 10.1016/s0168-8278(03)00191-0
  2. Sheriff S, Cammel G, Carey WD et al. The role of liver biopsy in chronic hepatitis C. Hepatology 2001; 33 (1): 196-200. doi: 10.1053/jhep.2001.20534
  3. Imamura H, Kawasaki S, Bandai Y et al. Comparison between wedge and needle biopsies for evaluating the degree of cirrhosis. J Hepatol 1993; 17 (2): 215-9. doi: 10.1016/S0168-8278(05)80041-8
  4. Kalambokis G, Manousou P, Vibhakorn S et al. Transjugular liver biopsy - indications, adequacy, quality of specimens, and complications - a systematic review. J Hepatol 2007; 47 (2): 284-94. doi: 10.1016/j.jhep.2007.05.001
  5. Nousbaum JB, Cadranel JF, Bonnemaison G et al. [Clinical practice guidelines on the use of liver biopsy. (In French).] Gastroenterol Clin Biol 2002; 26 (10): 848-78.
  6. Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol 2012; 19 (4): 250-62. doi: 10.1097/PAP.0b013e31825c6a20
  7. Волынец Г.В., Потапов А.С., Полякова С.И. и др. Определение степени нарушения функции печени у детей. Вопросы современной педиатрии. 2013; 12 (4): 47-51. PMID: 26281158 @@Volynets G.V., Potapov A.S., Poliakova S.I. et al. Opredelenie stepeni narusheniia funktsii pecheni u detei. Voprosy sovremennoi pediatrii. 2013; 12 (4): 47-51. PMID: 26281158 (in Russian).
  8. Маев И.В., Чарный А.М., Вьючнова Е.С. и др. Биопсия печени. Учебно-методическое пособие. М.: Издательство ИТРК, 2002. @@Mayev I.V., Charny A.M., Vyuchnova E.S. et al. Liver biopsy. Teaching aid. Moscow: Publishing house ITRK, 2002 (in Russian).
  9. Pokorska-Spiewak M, Kowalik-Mikotajewska B, Aniszewska M et al. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol 2015; (42): 12141-9. doi: 10.3748/wjg.v21.i42.12141
  10. Пинцани М. Эволюция фиброза печени: от гепатита к циррозу. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2002; 12 (5): 4. @@Pintsani M. Evoliutsiia fibroza pecheni: ot gepatita k tsirrozu. Ros. zhurn. gastroenterologii, gepatologii, koloproktologii. 2002; 12 (5): 4 (in Russian).
  11. Gagner M, Rogula T, Selzer D. Laparoscopic liver resection: benefits and controversies. Surgl Clin North Am 2004; 84 (2): 451-62. doi: 10.1016/j.suc.2003.11.002
  12. Moy L, Levine J. Autoimmune Hepatitis: A Classic Autoimmune Liver Disease. Cur Probl Ped Adolescent Health Care 2014; 44 (11): 341-6. doi: 10.1016/J.Cppeds.2014.10.005
  13. Александрова ЕА., Бурневич Э.З., Арион Е.А. Системные проявления первичного склерозирующего холангита. Клиническая медицина. 2013; 4: 38-42. @@Aleksandrova E.A., Burnevich E.Z., Arion E.A. Sistemnye proiavleniia pervichnogo skleroziruiushchego kholangita. Klinicheskaia meditsina. 2013; 4: 38-42 (in Russian).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74329 от 19.11.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies